Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23
Phase 31
Phase 41

Trial Status

Completed1
Other13

Role Distribution

Principal Investigator13
Other Roles1
PI Rate93%

Activity Timeline

Clinical Trials (14)

Radial Access for Abdominopelvic Vascular Intervention
Vascular Access Device Complications
PrincipalinvestigatorStart date: 2023-08-07
NCT05957640Phase 1Unknown
Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2023-05-05
NCT05692037Phase 1/2Unknown
Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases
Unresectable Colorectal Liver Metastases
PrincipalinvestigatorStart date: 2022-12-28
NCT05631561Not ApplicableUnknown
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
PrincipalinvestigatorStart date: 2022-12-27
NCT05344924Phase 2/3Unknown
TACE Combined With Penpulimab and Anlotinib for Advanced HCC
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2022-10-12
NCT05073744Phase 4Unknown
Nalbuphine Versus Morphine for Perioperative Tumor Ablation
AblationNalbuphine AllergySafety
PrincipalinvestigatorStart date: 2021-09-05
NCT04652492Phase 2Unknown
Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2020-10-27
NCT04060797Not ApplicableCompleted
Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease
PAD
PrincipalinvestigatorStart date: 2019-08-23
NCT03418415Not ApplicableUnknown
Renal Denervation in Patients With Type 2 Diabetes Mellitus
Renal DenervationType 2 Diabetes Mellitus
PrincipalinvestigatorStart date: 2018-01-18
NCT03431922Not ApplicableUnknown
Endovascular Denervation in Patients With Cancer Pain
Cancer Pain
PrincipalinvestigatorStart date: 2017-09-21

Showing 10 of 14 trials

Research Network

Collaboration Network

11 collaborators·52 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jian-Song Ji, MD

The Central Hospital of Lishui City

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Hao Xu, MD

XuZhou Medical College Affiliated Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

zhong-Min Wang, MD

Shanghai JiaoTong University Affiliated RuiJin Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Ming Huang, MD

Yunnan Cancer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Wei-Fu Lv, MD

China University of Science and Technology Affiliated the First Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Jun-Hui Sun, MD

Zhejiang University Affiliated the First Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Li-Gong Lu, MD

The People's Hospital of Zhuhai City

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Jian Wang, MD

Beijing University Affiliated the First Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Chuan-Sheng Zheng, MD

HuaZhong University of Science and Technology Affiliated Union Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Wen-Tao Li, MD

Fudan University Affiliated Cancer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Bile Duct CancerCancer of LiverCancer of Pancreas+1 more

Worked with same sponsors:

Shanghai Golden Leaf MedTec Co. Ltd
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (14)

Showing 14 of 14 trials

NCT05956860PrincipalInvestigator

Radial Access for Abdominopelvic Vascular Intervention

Vascular Access Device Complications
Unknown
NCT05957640Phase 1PrincipalInvestigator

Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma
Unknown
NCT05692037Phase 1/2PrincipalInvestigator

Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases

Unresectable Colorectal Liver Metastases
Unknown
NCT05631561Not ApplicablePrincipalInvestigator

Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)
Unknown
NCT05344924Phase 2/3PrincipalInvestigator

TACE Combined With Penpulimab and Anlotinib for Advanced HCC

Hepatocellular Carcinoma
Unknown
NCT05073744Phase 4PrincipalInvestigator

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

AblationNalbuphine AllergySafety
Unknown
NCT04652492Phase 2PrincipalInvestigator

Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
Unknown
NCT04060797Not ApplicablePrincipalInvestigator

Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease

PAD
Completed
NCT03418415Not ApplicablePrincipalInvestigator

Renal Denervation in Patients With Type 2 Diabetes Mellitus

Renal DenervationType 2 Diabetes Mellitus
Unknown
NCT03431922Not ApplicablePrincipalInvestigator

Endovascular Denervation in Patients With Cancer Pain

Cancer Pain
Unknown
NCT04014478Not ApplicableStudyChair

A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

Bile Duct CancerLiver CancerPancreas Cancer+1 more
Unknown
NCT05345431Not ApplicablePrincipalInvestigator

Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease

PAD
Unknown
NCT06021015Not ApplicablePrincipalInvestigator

Safety and Efficacy of Polyvinyl Alcohol Sodium Acrylate Embolization Microspheres for CRLM

Colorectal Cancer Liver Metastasis
Unknown
NCT06024252PrincipalInvestigator

Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study

HCC
Unknown

All 14 trials loaded